• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PET/CT 在原发性肝胆肿瘤治疗中的应用价值,第 2 部分。

Value of PET/CT in the management of primary hepatobiliary tumors, part 2.

机构信息

Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995.

DOI:10.2214/AJR.11.6995
PMID:21785051
Abstract

OBJECTIVE

Primary hepatobiliary malignancies consist of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. Benign hepatic lesions include hepatic cysts, hemagiomas, adenomas, and focal nodular hyperplasias. The utility of PET/CT in imaging primary hepatobiliary lesions varies according to the type and location of the lesion.

CONCLUSION

There is a consistent benefit to the use of PET/CT for detection and staging, and it ultimately helps to establish the best course of treatment and to determine prognosis. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for hepatobiliary malignancies.

摘要

目的

原发性肝胆恶性肿瘤包括肝细胞癌、胆管癌和胆囊癌。良性肝病变包括肝囊肿、血管瘤、腺瘤和局灶性结节性增生。PET/CT 在原发性肝胆病变成像中的应用价值取决于病变的类型和位置。

结论

PET/CT 的使用在检测和分期方面具有一致的益处,最终有助于确定最佳治疗方案并预测预后。此外,PET/CT 在肝胆恶性肿瘤的局部消融和系统治疗评估及监测中非常有用。

相似文献

1
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.PET/CT 在原发性肝胆肿瘤治疗中的应用价值,第 2 部分。
AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995.
2
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在胰腺癌和肝胆癌中的应用:对患者管理和预后的价值
PET Clin. 2015 Jul;10(3):327-43. doi: 10.1016/j.cpet.2015.03.001. Epub 2015 Apr 16.
3
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].[¹⁸F]氟代脱氧葡萄糖正电子发射断层扫描在胃肠道肿瘤诊断中的应用
Z Gastroenterol. 2008 Apr;46(4):367-75. doi: 10.1055/s-2007-963637.
4
Staging and follow-up of gastrointestinal tumors with PET/CT.胃肠道肿瘤的PET/CT分期及随访
Abdom Imaging. 2006 Jan-Feb;31(1):25-35. doi: 10.1007/s00261-005-0031-3.
5
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.18F-氟脱氧葡萄糖正电子发射断层扫描影响胆管癌患者的治疗决策。
J Am Coll Surg. 2008 Jan;206(1):57-65. doi: 10.1016/j.jamcollsurg.2007.07.002. Epub 2007 Oct 1.
6
The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描在胆管癌的诊断、分期和随访中的作用。
Surg Oncol. 2011 Mar;20(1):e10-7. doi: 10.1016/j.suronc.2009.08.003. Epub 2009 Oct 4.
7
[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.[F-18]氟脱氧葡萄糖正电子发射断层扫描及正电子发射断层扫描-计算机断层扫描在复发性和转移性胆管癌中的应用
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8. doi: 10.1097/01.rct.0000237811.88251.d7.
8
Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.18F-氟脱氧葡萄糖正电子发射断层扫描在胆管癌鉴别诊断及分期中的应用价值
J Gastroenterol Hepatol. 2008 May;23(5):759-65. doi: 10.1111/j.1440-1746.2007.05173.x. Epub 2007 Oct 10.
9
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.正电子发射断层扫描与计算机断层扫描联合应用对胆囊癌和胆管癌分期及治疗的影响
J Hepatol. 2006 Jul;45(1):43-50. doi: 10.1016/j.jhep.2006.03.009. Epub 2006 Apr 19.
10
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.正电子发射断层扫描(PET)与计算机断层扫描(CT)图像融合在肝细胞癌及合并肝细胞胆管癌伴肝外转移患者中的价值:初步研究结果。
Liver Int. 2006 Sep;26(7):781-8. doi: 10.1111/j.1478-3231.2006.01296.x.

引用本文的文献

1
Correlation between dual-time-point F-FDG PET/CT imaging and pathological grade in hepatocellular carcinoma.双时间点F-FDG PET/CT成像与肝细胞癌病理分级的相关性
Quant Imaging Med Surg. 2025 Aug 1;15(8):6801-6810. doi: 10.21037/qims-2025-196. Epub 2025 Jul 30.
2
PET imaging of hepatocellular carcinoma with [I]IV-14.使用[I]IV-14对肝细胞癌进行正电子发射断层显像(PET)成像。
EJNMMI Res. 2025 Apr 7;15(1):35. doi: 10.1186/s13550-025-01227-5.
3
F-FAPI-42 PET/CT for preoperatively identifying intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
F-FAPI-42 PET/CT用于术前鉴别肝内胆管癌和肝细胞癌。
Quant Imaging Med Surg. 2025 Jan 2;15(1):741-751. doi: 10.21037/qims-24-1489. Epub 2024 Dec 18.
4
PET/MRI: pictorial review of hepatobiliary and pancreatic applications.PET/MRI:肝胆胰应用的影像学综述
Abdom Radiol (NY). 2025 Feb;50(2):875-901. doi: 10.1007/s00261-024-04548-6. Epub 2024 Sep 10.
5
Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?主要器官中意外的局灶性氟脱氧葡萄糖摄取;是穿过还是经过?
World J Clin Cases. 2024 Apr 16;12(11):1885-1899. doi: 10.12998/wjcc.v12.i11.1885.
6
Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation.肝细胞癌:肝移植前的最佳影像学评估
Life (Basel). 2023 Nov 27;13(12):2267. doi: 10.3390/life13122267.
7
Intraoperative Imaging in Hepatopancreatobiliary Surgery.肝胆胰外科手术中的术中成像
Cancers (Basel). 2023 Jul 20;15(14):3694. doi: 10.3390/cancers15143694.
8
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
9
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.用于肝细胞癌成像的正电子发射断层显像(PET)放射性药物的最新进展
Cancers (Basel). 2023 Mar 25;15(7):1975. doi: 10.3390/cancers15071975.
10
Comparison between PSMA PET/CT and MRI for Characterizing : A Real-World Study.PSMA PET/CT 与 MRI 对前列腺癌特征分析的比较:一项真实世界研究。
Tomography. 2023 Jan 13;9(1):130-138. doi: 10.3390/tomography9010011.